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Response to Smith et al.
Smith et al.'s criticisms ofour commentary
in EHP(102:354-356) fall into four gener-
al categories: arsenic methylation and detox-
ification; the recalculation of the slope fac-
tor for ingested arsenic; differences between
U.S. and Taiwanese populations; and recent
epidemiological analyses. As discussed
below, we stand by our earlier conclusion
that the dose-response relationship for
arsenic carcinogenicity is likely to be nonlin-
ear, and we feel that there is no basis for dis-
missing the methylation saturation hypothe-
sis as one possible explanation for nonlinear-
ity. We offer the following response to
Smith et al.'s criticisms.
Arsenic methylation: We acknowledge
that the issue of arsenic methylation and
detoxification is complex; however, we
believe that the methodological limitations
we observed in the Hopenhayn-Rich et al.
(1) article on arsenic methylation weaken
their argument that human studies do not
support a methylation threshold hypothe-
sis for arsenic. Moreover, we call readers'
attention to several recent studies that sug-
gest that percent inorganic arsenic in urine
is not as sensitive an indicator ofthe satu-
ration ofthe methylation pathway as is the
ratio of the percentage of urinary metabo-
lites, MMA to DMA. Hughes et al. (2)
demonstrated an increase in the relative
percentage ofMMA to DMA (per admin-
istered dose of arsenic) excreted in the
urine ofmice, with increase in dose. In sin-
gle oral doses ranging from 0.5 to 5000
pg/kg, the ratio of MMA to DMA
increased by approximately a factor of 10
from the lowest to the highest group. The
relative percent ofinorganic arsenic bound
to tissue also increased with dose. The
authors propose that inorganic arsenic
binds to macromolecules and does not
appear in urine until the binding becomes
saturated. Therefore, inorganic arsenic is
not as sensitive an indicator of saturation
of the methylation pathway as is the con-
centration of methylated metabolites.
Similarly, in an epidemiological study of
humans exposed to elevated levels of
arsenic in drinking water in Mexico, Del
Razo et al. (3) report that the MMA:DMA
ratio in urine was significantly increased in
the study group by a factor of 2.4 times
relative to that in the control population.
In another epidemiological investigation of
increased levels ofarsenic in drinking water
in northeast Taiwan, Froines (4) observed
a statistical increase of 1.5 times in the
ratio of percentages of urinary MMA:
DMA in the exposed population relative to
the controls.
In our commentary, we stated that
Smith et al. (5) did not discuss the implica-
tions ofdetoxification in estimating poten-
tial risks from low-level exposures typical
of the U.S. population. To be more pre-
cise, we should have stated that although
Smith et al. briefly discussed methylation,
they neglected to adequately consider some
of the evidence that suggests there may be
a saturation level for the methylation reac-
tion, and therefore discounted the role of
detoxification in the dose-response rela-
tionship for arsenic carcinogenicity.
Smith et al. refer to studies in Chile
and Nevada which further support their
position regarding a lack of evidence for
saturation ofthe methylation pathway. We
recommend that these studies, as well as
other published data, be reviewed to see
whether MMA:DMA ratios change, on an
individual subject basis, with increasing
dose.
Issues concerning the recalculation ofthe
slopefactor: As Smith et al. have noted, we
incorrectly stated in our original commen-
tary that assuming a zero arsenic intake for
the control population would artificially
increase the slope ofthe exposure-response
curve. By assuming a zero intake for the
control population, Smith et al. did indeed
calculate a shallower slope, using a simple
linear regression, than would have been
calculated if the control population alone
had been assumed to have increased arsenic
exposure (and all other assumptions and
data points remained the same). We
should have stated that a more accurate
representation of the arsenic exposure for
all exposure groups, including careful
considerations of background dietary
arsenic intake and water consumption rates
in both exposed and control groups, as
well as the use of a more appropriate
dose-response model, would result in a sig-
nificantly decreased cancer slope factor
(CSF) and lower risks.
Background levels ofarsenic in the diet
should be considered as part ofexposure in
all groups, since elevated levels ofinorganic
arsenic have been shown to be present in
the food supply in Taiwan. Recent analyses
have suggested that the actual amount of
inorganic arsenic in the Taiwanese diet
may range from 62 to 290 pg per day (6).
Thus, dietary intake of arsenic in control
populations is unlikely to be "virtually
zero," as Smith et al. have suggested, and
estimates of dietary arsenic should be
added to all exposure groups, including the
control group.
As an example of the impact of back-
ground arsenic intake on estimates ofcan-
cer risk, Yost et al. (6) have shown that
EPA's current CSF for arsenic, calculated
using a linearized multistage model, would
be lowered from 1.75 to as little as 0.13
kg-day/mg by correcting for background
dietary sources of inorganic arsenic. Had
Smith et al. (5) used these estimates of
dietary arsenic intake in their analyses, an
overall decrease in calculated risks for
internal cancers would have been expected.
However, this lowered risk would be
reflected in Smith et al. (5) as a change in
the intercept, but not the slope, of the
exposure-response curve because they used
simple linear regression to model total (as
opposed to excess) mortality.
Water ingestion rates also can signifi-
cantly affect total arsenic exposure and the
calculation of cancer slope factors. As dis-
cussed in our commentary, EPA has
recently approved an RfD for arsenic based
on Taiwanese data and a water consump-
tion rate of4.5 1/day for males and females
(7). While it is true that EPAhad previous-
ly estimated Taiwanese water intake to be
3.5 1/day for males and 2 1/day for females
(8), the characterization by Smith et al.
that the more recent estimate of4.5 1/day
comes from "a speculative EPA staff dis-
cussion with virtually no data to support
it" is inappropriate. Abernathy and his col-
leagues considered discussions of water
consumption rates with several individuals
from a Taiwanese Blackfoot treatment cen-
Volume 103, Number 1, January 1995 15- .e 9-
-
ter as well as realistic estimates of direct
and indirect water consumption (9). While
more conclusive studies ofwater consump-
tions rates in Taiwan are desirable and
have not been performed, the recommen-
dation of 4.5 I/day is, in our opinion, the
most reasonable estimate of Taiwanese
water ingestion rates available.
Furthermore, adjustment of the drinking
water consumption rate has more than a
"small effect on risk estimates." By using a
water consumption rate of 4.5 1/day, as
opposed to 3.5 and 2 1/day for males and
females, respectively, EPA's current CSF
for skin cancer would be decreased from
1.75 to 0.89 kg-day/mg, a 51% reduction
(10). Once again, an overall lowering of
risks calculated for internal cancers would
be expected if Smith et al. had adjusted
their assumptions regarding water intake.
Differences between U.S. and Taiwanese
populations: Because the body's ability to
efficiently detoxify arsenic is dependent on
its methylation ability, individuals with
diets deficient in factors that are necessary
for methylation may have an increased risk
for the toxic effects of arsenic (8).
Methionine and cysteine are two amino
acids necessary for methylation that are
components of the protein ingested in a
healthy diet. We agree with Smith and co-
workers that the Taiwanese study popula-
tion, the Taiwanese average population,
and the U.S. average population all exceed
the recommended dietary allowance
(RDA) for methionine plus cysteine of0.9
g/day for a 70-kg adult male and 0.7 g/day
for a 54-kg male. However, it is not
known how excessive arsenic body burden
(as experienced by the Taiwanese popula-
tion) may quantitatively affect methyl
donor group demand and, consequently,
the efficiency of the body's methylation
detoxification pathway. In fact, the impact
of added demand for methyl groups from
methionine and cysteine for xenobiotic
detoxification is not considered in the
RDA. Several animal studies provide
strong evidence that amino acid deficien-
cies in the diet may adversely impact the
body's ability to detoxify arsenic (11,12). It
must be considered that the Taiwanese
intake of methionine and cysteine, which
is one-halfthat ofthe U.S. intake on a per
killigram body weight basis (13-15), could
affect the detoxification ability under con-
ditions ofhigh demand for methyl groups
due to excessive arsenic burden.
We acknowledge that Smith et al. dis-
cussed the role of humic acids as being
possible confounders in the association
between arsenic in drinking water and the
incidence of internal cancers in an earlier
paper (16). However, the conclusion that
"there is little, if any, evidence to support
the claim that humic substances are the
causes of disease in the blackfoot disease
endemic area of Taiwan" ignores the fact
that humic acid levels co-vary significantly
with both arsenic in water [correlation
coefficient of 0.42, p<0.05 (17) and the
average annual incidence rate of bladder
cancer. In addition, fluorescent substances
humicc acids) isolated from the drinking
water of the blackfoot endemic area in
southeastern Taiwan have been found to
be mutagenic (18). Lu et al. (19) reported
that humic acid-arsenic complexes admin-
istered to mice induced liver enzymes and
caused liver peroxidation, whereas humic
acid complexes with other metals did not.
Thus, the potential impact ofhumic acids
on cancer incidence should not be dis-
counted.
Recent epidemiological analyses: We
acknowledge the limitations of ecological
epidemiological studies, where subjects are
studied in groups and the exposure ofeach
group is represented by a single figure.
Both the Tseng et al. (20) and Guo et al.
(21) studies are ecological epidemiological
studies. However, we feel that the Guo et
al. analysis represents a refinement over the
Tseng analysis in that it does not make the
assumption of a linear no-threshold
dose-response relationship. Tseng uses
median arsenic concentrations for all wells
in a village to represent exposure to each
village inhabitant. Guo et al. use a similar
method but also use multiple variable
regression models to describe exposure sta-
tus, such that the distribution of arsenic
concentrations in wells within a township
is considered explicitly. Both Guo's tradi-
tional and multiple regression analyses pro-
duce statistically significant associations
between arsenic levels and bladder cancers;
however, the associations estimated using
the new method are more complex and
suggest the possibility of a nonlinear
dose-response relationship.
It is also important to note that the
Tseng analysis and others may have under-
estimated exposure (and thus overestimat-
ed potency), particularly in the low-dose
groups, by using the median rather than
the mean arsenic concentration per village
to represent exposure. In villages with a
distribution of well water arsenic concen-
trations that is skewed to the right (because
there are a few wells with high arsenic lev-
els), the median arsenic concentration will
be considerably lower than the mean. In
this case, ifthe fraction ofpeople ingesting
water at a defined arsenic level is directly
proportional to the number of wells at a
defined arsenic level, the mean arsenic con-
centration of population exposure would
be a better estimate of exposure than the
median. In villages with a more normal or
uniform distribution of well water arsenic
concentrations, the mean and median val-
ues would be more similar. Thus, use of
the median rather than mean arsenic con-
centration to represent exposure could arti-
ficially increase the magnitude of effect
observed. Specifically, ifthe distribution of
arsenic in wells in the low-arsenic villages
(most wells low with one or two high lev-
els) is more skewed than in the higher-
arsenic villages (most wells high), use of
the median to represent exposure would
specifically increase the magnitude of the
effect observed at low doses relative to high
doses.
As a final note, we call attention to a
more recent analysis by the Drinking
Water Committee of EPA's Science
Advisory Board (22), prepared as part of a
review of EPA's draft Drinking Water
Criteria document on Inorganic Arsenic
(23). The Science Advisory Board agreed
with EPA that there was an association
between internal cancer and exposure to
high levels of arsenic in drinking water.
However, the board pointed to key uncer-
tainties in the extrapolation ofresults from
the Taiwanese population to U.S. popula-
tions which needed to be addressed before
completing any quantitative risk assess-
ment. Specifically, the board referred to
data indicating that blood arsenic levels
only become elevated when the levels of
arsenic in water exceed 100 pg/l (24), sug-
gesting nonlinearities in the pharmacoki-
netics of arsenic. They also referred to the
importance of considering exposure to
other sources of arsenic in the Taiwanese
population, as indicated by higher blood
arsenic levels in the general Taiwanese
population as compared to Danish (25) or
U.S. (24) populations.
B.D. Beck
P.D. Boardman
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